Niche Biomedical
About:
Niche Biomedical deals with the research and development of neuromodulation devices to improve human health.
Website: https://nichebio.com
Top Investors: National Science Foundation
Description:
ANEUVO® is a Platform and Therapy Development firm focused on treating chronic injuries and disorders that have not been treated successfully with existing pharmacological techniques. ExaStim® is an FDA Breakthrough Device Designated non-invasive neuromodulation system created by ANEUVO for the treatment of spinal cord injury.
Total Funding Amount:
$1.45M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Los Angeles, California, United States
Founded Date:
2016-01-01
Contact Email:
contactus(AT)nichebio.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2021-08-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai